Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Current Treatment Options in Oncology|December 20, 2019
Opioid-Induced Constipation in Oncological Patients: New Strategies of ManagementRicard Mesía, Juan Antonio Virizuela Echaburu, Jose Gómez, et al.
Cancer Metastasis Reviews|June 23, 2012
The role of pharmacogenomics in metastatic renal cell carcinomaDaniel Castellano, Juan Antonio Virizuela, Josefina Cruz, et al.
Pathology Oncology Research : POR|February 1, 2011
Gastrointestinal stromal tumors: morphological, immunohistochemical and molecular changes associated with kinase inhibitor therapyMario Díaz Delgado, Alicia Hernández Amate, Sofía Pereira Gallardo, et al.
The Lancet. Oncology|February 19, 2010
Activity of a multitargeted chemo-switch regimen (sorafenib, gemcitabine, and metronomic capecitabine) in metastatic renal-cell carcinoma: a phase 2 study (SOGUG-02-06)Joaquim Bellmunt, José Manuel Trigo, Emiliano Calvo, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 4, 2015
SIADH-related hyponatremia in hospital day care units: clinical experience and management with tolvaptanRamón De Las Peñas, Santiago Ponce, Fernando Henao, et al.
Pathology Oncology Research : POR|October 9, 2007
Expression of P-glycoprotein and metallothionein in gastrointestinal stromal tumor and leiomyosarcomas. Clinical implicationsSofia Pérez-Gutiérrez, Ricardo González-Cámpora, Joaquín Amérigo-Navarro, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 29, 2022
SEOM clinical guideline emesis (2021)Margarita Majem, Ramon de Las Peñas, Juan Antonio Virizuela, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|August 18, 2015
Management of Infection and Febrile Neutropenia in Patients with Solid CancerJosé María Aguado, Juan Jesús Cruz, Juan Antonio Virizuela, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 27, 2016
Equity, barriers and cancer disparities: study of the Spanish Society of Medical Oncology on the access to oncologic drugs in the Spanish RegionsJavier Salvador, Jorge Aparicio, Francisco Javier Baron, et al.
European Urology Oncology|November 18, 2025
Patient-reported Outcomes for Men with Metastatic Castration-resistant Prostate Cancer Who Received Olaparib plus Abiraterone Versus Placebo plus Abiraterone in the Phase 3 PROpel StudyAndrew J Armstrong, Fred Saad, Mototsugu Oya, et al.
Pageof 3